Case number 1:17-cv-00005
Sanofi-Aventis U.S. LLC et al v. Mylan Pharmaceuticals, Inc. et al > Summary
Court Case Number 1:17-cv-00005
Filing Date Jan 12, 2017
Termination Date Dec 28, 2017
Court West Virginia Northern District Court
Status Dismissed - Other
JudgesIrene M. Keeley
Plaintiff Attorneys
U.S.A. Inc.
Attorney Name: David J. Perri
US Attorney's Office
Defendant Attorneys
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09186346 | Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients | Nov 17, 2015 |
| 08802735 | (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability | Aug 12, 2014 |
| 06794410 | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4-trifluoromethylphenyl)-amide for treating multiple sclerosis | Sep 21, 2004 |
